Raymond James & Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,570
| Closed | -$1.21M | – | 4299 |
|
|
2021
Q1 | $1.21M | Sell |
5,570
-3,055
| -35% | -$574K | ﹤0.01% | 2376 |
|
|
2020
Q4 | $995K | Sell |
8,625
-13,966
| -62% | -$1.56M | ﹤0.01% | 2352 |
|
|
2020
Q3 | $2.2M | Buy |
22,591
+7,415
| +49% | +$853K | ﹤0.01% | 1704 |
|
|
2020
Q2 | $1.86M | Sell |
15,176
-120
| -0.8% | -$13.6K | ﹤0.01% | 1775 |
|
|
2020
Q1 | $1.34M | Buy |
15,296
+205
| +1% | +$21.7K | ﹤0.01% | 1802 |
|
|
2019
Q4 | $1.58M | Sell |
15,091
-1
| -0% | -$112 | ﹤0.01% | 1981 |
|
|
2019
Q3 | $1.74M | Sell |
15,092
-2,209
| -13% | -$335K | ﹤0.01% | 1859 |
|
|
2019
Q2 | $2.98M | Sell |
17,301
-948
| -5% | -$164K | ﹤0.01% | 1544 |
|
|
2019
Q1 | $3.08M | Sell |
18,249
-3,968
| -18% | -$590K | ﹤0.01% | 1497 |
|
|
2018
Q4 | $2.16M | Sell |
22,217
-3,474
| -14% | -$456K | ﹤0.01% | 1603 |
|
|
2018
Q3 | $4.44M | Buy |
25,691
+4,791
| +23% | +$691K | 0.01% | 1289 |
|
|
2018
Q2 | $2.92M | Buy |
20,900
+9,143
| +78% | +$1.3M | ﹤0.01% | 1526 |
|
|
2018
Q1 | $1.32M | Buy |
11,757
+3,293
| +39% | +$414K | ﹤0.01% | 1947 |
|
|
2017
Q4 | $1.12M | Buy |
8,464
+718
| +9% | +$84.4K | ﹤0.01% | 2061 |
|
|
2017
Q3 | $786K | Buy |
7,746
+763
| +11% | +$81.7K | ﹤0.01% | 2236 |
|
|
2017
Q2 | $700K | Buy |
6,983
+1,374
| +24% | +$148K | ﹤0.01% | 2235 |
|
|
2017
Q1 | $678K | Buy |
5,609
+1,711
| +44% | +$210K | ﹤0.01% | 2202 |
|
|
2016
Q4 | $436K | Buy |
3,898
+846
| +28% | +$102K | ﹤0.01% | 2414 |
|
|
2016
Q3 | $405K | Buy |
+3,052
| New | +$292K | ﹤0.01% | 2416 |
|
Other funds holding GWPH
Raymond James & Associates's GWPH Position: Q2 2021 in Review
Raymond James & Associates sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 5,570 shares — an estimated $1.21M sold.
Raymond James & Associates first reported a position in GWPH in Q3 2016 and held it in 19 quarters. The position peaked at $4.44M in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Raymond James & Associates reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Raymond James & Associates sold 5,570 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.21M.
- Raymond James & Associates first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2016 and held it in 19 quarters.
- Raymond James & Associates's GW Pharmaceuticals Plc American Depositary Shares position peaked at $4.44M in Q3 2018.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.